Efficacy and safety of PD‐1/PD‐L1 inhibitors in elderly patients with advanced non‐small cell lung cancer
Abstract Objective This study aimed to investigate the efficacy and safety of PD‐1/PD‐L1 inhibitors in treatment of elderly patients with advanced non‐small cell lung cancer (NSCLC). Methods Patients with advanced NSCLC ≥70 years old who received PD‐1/PD‐L1 inhibitors in our hospital were retrospect...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2024-05-01
|
| Collection: | The Clinical Respiratory Journal |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1111/crj.13763 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|